Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XP Chemistries is a Swedish biotechnology company specializing in the sustainable production of capsaicin and its analogues from forest-based raw materials. Utilizing a patented green chemistry platform developed at Mid Sweden University, the company offers high-purity, eco-friendly alternatives to traditionally extracted capsaicin for use in animal feed, personal care, and pharmaceutical applications. Their technology aims to replace synthetic or resource-intensive production methods with a renewable, biomass-derived process. XP Chemistries is publicly traded on the Nasdaq First North Growth Market and is focused on expanding its global distribution network for bio-based fine chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XP Chemistries.